COVID-19 studies:  C19 studies: C19:  IvermectinIVM Vitamin DV.D PXPX FLVFLV PVP-IPI BUBU BHBH BLBL CICI HC QHC Q NZNZ COCO More..
Vitamin D study #1 of 109
2010 Pre-Exposure Prophylaxis study (treated before exposed to the virus)
Urashima et al., Am. J. Clin. Nutr. 2010, 91:5, 1255-60, doi:10.3945/ajcn.2009.29094 (Peer Reviewed)
Randomized trial of vitamin D supplementation to prevent seasonal influenza A in schoolchildren
Source   PDF   Share   Tweet
RCT for vitamin D supplementation and seasonal influenza A in schoolchildren, showing 10.8% incidence in children in the vitamin D3 group compared with 18.6% in the placebo group, relative risk RR 0.58 [0.34-0.99], p = 0.04.
The reduction was more prominent in children who had not been taking other vitamin D supplements. RR 0.36 [0.17-0.79], p 0.006, and who started nursery school after age 3y, RR 0.36 [0.17-0.78], p = 0.005.
Reduced incidence of influenza B was not seen, RR 1.39 [0.90-2.15], p = 0.13.

Urashima et al., 1/1/2010, peer-reviewed, 6 authors.
All 109 studies
Please send us corrections, updates, or comments. Vaccines and treatments are both extremely valuable and complementary. All practical, effective, and safe means should be used. Elimination of COVID-19 is a race against viral evolution. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. Denying the efficacy of any method increases the risk of COVID-19 becoming endemic; and increases mortality, morbidity, and collateral damage. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. Treatment protocols for physicians are available from the FLCCC.
  or use drag and drop to submit images